MiNK Therapeutics, Inc.

NASDAQ:INKT

0.575 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 6.3289.3145.8173.3676.39910.62214.89219.63624.15929.84734.68838.8890.8191.658-2.6912.691-0.299
Short Term Investments 000000000000005.38200.598
Cash and Short Term Investments 6.3289.3145.8173.3676.39910.62214.89219.63624.15929.84734.68838.8890.8191.6582.6912.6910.299
Net Receivables 000000000000.0230.0350000
Inventory 000000000000.0022.5762.23201.0310
Other Current Assets 0.2470.160.1820.2310.0710.4320.630.7690.30.4830.7880.7232.5872.54201.4060
Total Current Assets 6.5759.4745.9993.5986.4711.05415.52220.40524.45930.32935.47739.6353.4424.2012.6914.0970.299
Non-Current Assets:
Property, Plant & Equipment, Net 0.80.850.8950.9540.9911.0581.0671.0670.8030.7880.6650.6070.6360.55200.4580
Goodwill 00000000000000000
Intangible Assets 00000000000000000
Goodwill and Intangible Assets 00000000000000000
Long Term Investments 00000000000000000
Tax Assets 00000000000000000
Other Non-Current Assets 000-00-0-0-0-0-00000-2.6910-0.299
Total Non-Current Assets 0.80.850.8950.9540.9911.0581.0671.0670.8030.7880.6650.6070.6360.552-2.6910.458-0.299
Total Assets 7.37510.3246.8944.5527.46212.11216.58921.47225.26231.11736.14240.2424.0774.75304.5550
Liabilities & Equity:
Current Liabilities:
Account Payables 2.3613.2023.4873.9124.2814.8866.0025.8235.1724.7913.7272.9961.6482.26803.1420
Short Term Debt 00000000000065.42352.526000
Tax Payables 0000000000000000.3240
Deferred Revenue 0000000000008.1127.242000
Other Current Liabilities 5.0386.9457.6217.4916.1136.5795.2486.8613.27612.63715.10713.46913.48912.754010.7560
Total Current Liabilities 7.39910.14711.10811.40310.39411.46511.2512.68318.44817.42718.83416.46580.56167.548014.2220
Non-Current Liabilities:
Long Term Debt 4.6124.4064.21200000000000043.8240
Deferred Revenue Non-Current 00000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000
Other Non-Current Liabilities 12.91812.34711.87311.20510.64810.1429.8159.190.0580000.0280.38300.3830
Total Non-Current Liabilities 17.5316.75216.08511.20510.64810.1429.8159.190.0584.7913.7272.9960.0280.383044.2070
Total Liabilities 24.92926.927.19322.60821.04221.60721.06521.87318.50617.42718.83416.46580.58967.931058.4290
Equity:
Preferred Stock 00000000000000000
Common Stock 00000000000000000
Retained Earnings -141,718.631-139.912-137.21-133.397-127.938-122.822-116.625-110.939-103.169-96.838-90.725-82.948-77.184-62.9160-52.7350
Accumulated Other Comprehensive Income/Loss -672.838-0.611-0.386-0.431-0.313-0.402-0.374-0.292-0.0781.297-0.102-0.625-0.789-1.335-53.874-1.523-36.334
Other Total Stockholders Equity 142,373.915123.947117.296115.772114.67113.728112.523110.83110.003109.23108.135107.3491.4621.07400.3840
Total Shareholders Equity -17.554-16.576-20.299-18.055-13.581-9.495-4.476-0.4016.75613.6917.30823.776-76.511-63.178-53.874-53.874-36.334
Total Equity -17.554-16.576-20.299-18.055-13.581-9.495-4.476-0.4016.75613.6917.30823.776-76.511-63.178-53.874-53.874-36.334
Total Liabilities & Shareholders Equity 7.37510.3246.8944.5527.46212.11216.58921.47225.26231.11736.14240.2424.0774.753-53.8744.555-36.334